These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22101269)

  • 1. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
    Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
    Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.
    Pieraccioli M; Imbastari F; Antonov A; Melino G; Raschellà G
    Cell Cycle; 2013 Jul; 12(14):2309-20. PubMed ID: 24067373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
    Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.
    Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ
    Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.
    Gao Y; Zhang W; Liu C; Li G
    Sci Rep; 2019 Dec; 9(1):18844. PubMed ID: 31827114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.
    Tanno B; Sesti F; Cesi V; Bossi G; Ferrari-Amorotti G; Bussolari R; Tirindelli D; Calabretta B; Raschellà G
    J Biol Chem; 2010 Sep; 285(38):29434-45. PubMed ID: 20622260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
    Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
    Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
    De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
    Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
    Chen J; Huang X; Li N; Liu B; Ma Z; Ling J; Yang W; Li T
    Mol Med Rep; 2020 Dec; 22(6):5113-5124. PubMed ID: 33174044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.